JP2010529958A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010529958A5 JP2010529958A5 JP2010510812A JP2010510812A JP2010529958A5 JP 2010529958 A5 JP2010529958 A5 JP 2010529958A5 JP 2010510812 A JP2010510812 A JP 2010510812A JP 2010510812 A JP2010510812 A JP 2010510812A JP 2010529958 A5 JP2010529958 A5 JP 2010529958A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- group
- disease
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07109652A EP2027889A1 (en) | 2007-06-05 | 2007-06-05 | New neuronal viability factor and use thereof |
| EP07109652.3 | 2007-06-05 | ||
| PCT/EP2008/057031 WO2008148860A1 (en) | 2007-06-05 | 2008-06-05 | New neuronal viability factor and use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010529958A JP2010529958A (ja) | 2010-09-02 |
| JP2010529958A5 true JP2010529958A5 (enExample) | 2011-07-21 |
| JP5671678B2 JP5671678B2 (ja) | 2015-02-18 |
Family
ID=38573348
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010510812A Active JP5671678B2 (ja) | 2007-06-05 | 2008-06-05 | ニューロン生存因子およびその使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (5) | US9575075B2 (enExample) |
| EP (2) | EP2027889A1 (enExample) |
| JP (1) | JP5671678B2 (enExample) |
| ES (1) | ES2623464T3 (enExample) |
| WO (1) | WO2008148860A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7261544B2 (en) | 2003-05-21 | 2007-08-28 | Genzyme Corporation | Methods for producing preparations of recombinant AAV virions substantially free of empty capsids |
| EP2027889A1 (en) * | 2007-06-05 | 2009-02-25 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | New neuronal viability factor and use thereof |
| EP2281047B1 (en) | 2008-04-15 | 2020-04-08 | Genzyme Corporation | Methods to produce rod-derived cone viability factor (rdcvf) |
| EP2383286A1 (en) | 2010-04-30 | 2011-11-02 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and compositions for treatment of retinal degenerative diseases |
| BR112014010091B1 (pt) | 2011-10-27 | 2022-11-08 | Wellstat Ophthalmics Corporation | Ácido nucleico, vetor viral, preparação farmacêutica, uso destes, método para produção de uma proteína rdcvf, e método in vitro ou ex vivo de secreção de uma proteína rdcvf a partir de uma célula |
| US9265786B1 (en) * | 2012-03-30 | 2016-02-23 | University Of Wyoming | Method for reducing protein misfolding and accumulation in Huntington'S disease cells |
| JP6684343B2 (ja) | 2015-05-21 | 2020-04-22 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | ニューロン生存因子の相乗組み合わせ及びその使用 |
| BR112018076674A2 (pt) | 2016-10-11 | 2019-04-02 | Wellstat Ophthalmics Corporation | proteína de fusão entre o fator de viabilidade do cone derivado de bastonetes de forma curta e um peptídeo hidrofílico |
| EP3570895A1 (en) | 2017-01-17 | 2019-11-27 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods of expressing a polynucleotide of interest in the cone photoreceptors |
| KR102763312B1 (ko) | 2017-10-20 | 2025-02-07 | 인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) | 치료적으로 유효한 양의 재조합 aav9- 유도 벡터의 망막하 전달을 포함하는 대상체의 원추 광수용체 내 관심의 폴리뉴클레오티드를 발현하는 방법 |
| ES2949484T3 (es) | 2017-12-22 | 2023-09-28 | Sparingvision | Construcciones que comprenden factores de viabilidad neuronal y usos de las mismas |
| US20240197913A1 (en) | 2021-04-20 | 2024-06-20 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Compositions and methods for treating retinal degenerative disorders |
| EP4366757A1 (en) * | 2021-07-07 | 2024-05-15 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Synergistic combination of rdcfv2 and rdcvf2l for the treatment of tauopathies |
| EP4605537A1 (en) | 2022-10-20 | 2025-08-27 | Sparingvision | Compositions and methods for treating retinal degenerative disorders |
| US20240342313A1 (en) | 2023-03-30 | 2024-10-17 | Pharma Cinq, Llc | Vector encoding rod-derived cone viability factor and human igk signal sequence |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1242443A4 (en) * | 1999-12-23 | 2005-06-22 | Nuvelo Inc | NEW NUCLEIC ACIDS AND POLYPEPTIDES |
| FR2823221B1 (fr) * | 2001-04-06 | 2004-04-02 | Univ Pasteur | Sequences associees a la degenerescence retinienne et applications |
| FR2870241B1 (fr) * | 2004-05-13 | 2015-02-27 | Novartis Ag | Facteur de viabilite des cones derive des batonnets ou rdcvf et applications |
| US20090011040A1 (en) * | 2007-05-02 | 2009-01-08 | Naash Muna I | Use of compacted nucleic acid nanoparticles in non-viral treatments of ocular diseases |
| EP2027889A1 (en) * | 2007-06-05 | 2009-02-25 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | New neuronal viability factor and use thereof |
| WO2009071659A1 (en) * | 2007-12-06 | 2009-06-11 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Trophic factor for the treatment of retinal degenerative diseases |
| JP5748223B2 (ja) * | 2008-09-10 | 2015-07-15 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | ニューロン生存因子およびその使用 |
| BR112014010091B1 (pt) * | 2011-10-27 | 2022-11-08 | Wellstat Ophthalmics Corporation | Ácido nucleico, vetor viral, preparação farmacêutica, uso destes, método para produção de uma proteína rdcvf, e método in vitro ou ex vivo de secreção de uma proteína rdcvf a partir de uma célula |
| JP6684343B2 (ja) * | 2015-05-21 | 2020-04-22 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | ニューロン生存因子の相乗組み合わせ及びその使用 |
| KR102763312B1 (ko) * | 2017-10-20 | 2025-02-07 | 인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) | 치료적으로 유효한 양의 재조합 aav9- 유도 벡터의 망막하 전달을 포함하는 대상체의 원추 광수용체 내 관심의 폴리뉴클레오티드를 발현하는 방법 |
| ES2949484T3 (es) * | 2017-12-22 | 2023-09-28 | Sparingvision | Construcciones que comprenden factores de viabilidad neuronal y usos de las mismas |
-
2007
- 2007-06-05 EP EP07109652A patent/EP2027889A1/en not_active Withdrawn
-
2008
- 2008-06-05 JP JP2010510812A patent/JP5671678B2/ja active Active
- 2008-06-05 WO PCT/EP2008/057031 patent/WO2008148860A1/en not_active Ceased
- 2008-06-05 US US12/602,736 patent/US9575075B2/en active Active
- 2008-06-05 EP EP08760606.7A patent/EP2175932B1/en active Active
- 2008-06-05 ES ES08760606.7T patent/ES2623464T3/es active Active
-
2016
- 2016-07-08 US US15/205,797 patent/US20170014478A1/en not_active Abandoned
-
2018
- 2018-10-02 US US16/149,420 patent/US20190064189A1/en not_active Abandoned
-
2019
- 2019-12-12 US US16/711,492 patent/US11428698B2/en active Active
-
2022
- 2022-07-18 US US17/866,900 patent/US20220404376A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Fang et al. | Adaptations to a subterranean environment and longevity revealed by the analysis of mole rat genomes | |
| AU2024201282A1 (en) | Compositions and methods for treating autoimmune diseases and cancers | |
| RS64769B1 (sr) | Varijante adeno-asociranih virusa i postupci upotrebe | |
| IL268417B2 (en) | Methods for cell-type specific profiling to identify drug targets | |
| Xu et al. | The soil emergence-related transcription factor PIF3 controls root penetration by interacting with the receptor kinase FER | |
| US20210172017A1 (en) | Methods of in vivo evaluation of gene function | |
| JP2017501697A (ja) | サルモネラ菌の非コードｒｎａおよびその同定と使用 | |
| US20220235102A1 (en) | Specific nuclear-anchored independent labeling system | |
| Wu et al. | Transcriptome analysis of different sizes of 3‐mercaptopropionic acid‐modified cadmium telluride quantum dot‐induced toxic effects reveals immune response in rat hippocampus | |
| US20250154498A1 (en) | Reagents for subcellular delivery of cargo to target cells | |
| CN110760511B (zh) | 一种用于治疗杜氏肌营养不良症的gRNA、表达载体、CRISPR-Cas9系统 | |
| CN113711046A (zh) | 用于揭示与Tau聚集相关的基因脆弱性的CRISPR/Cas脱落筛选平台 | |
| Lucibelli et al. | Extending the toolkit for beauty: Differential co-expression of DROOPING LEAF-like and class B MADS-Box genes during Phalaenopsis flower development | |
| WO2023143150A1 (zh) | 新型Cas酶和系统以及应用 | |
| US20060003959A1 (en) | Methods and agents for maintaining muscle mass and for preventing muscle atrophy and biomarkers for monitoring same | |
| Brimacombe et al. | Cloning and embryonic expression patterns of the chicken CELF family | |
| Çakır et al. | De novo transcriptome assembly and comparative analysis elucidate complicated mechanism regulating Astragalus chrysochlorus response to selenium stimuli | |
| CN108779495A (zh) | 调节bckdh的方法 | |
| Tian et al. | Comparative genomics provides insights into chromosomal evolution and immunological adaptation in horseshoe bats | |
| CN115867678A (zh) | 鉴定和表征指环病毒的方法及其用途 | |
| CN109134633A (zh) | 抗稻瘟病蛋白和基因、分离的核酸及其应用 | |
| JP2016534752A (ja) | 酸化ストレス、およびｄｎａに対する損傷によって引き起こされる疾患を処置するための、ｇｓｅ２４．２に由来するペプチド | |
| US20240060963A1 (en) | Compositions for detecting secretion and methods of use | |
| CN1914336B (zh) | 犬骨关节炎相关基因及相关的方法和组合物 | |
| KR102533992B1 (ko) | 세포에의 외래 유전자 도입 확인 방법 및 외래 유전자 도입 세포의 제조 방법 |